Nanomedicine 2.0

Warren C.W. Chan

doi:10.1021/acs.accounts.6b00629

Nanomedicine 2.0

Warren C.W. Chan^*

^*Corresponding author for this work

University of Toronto

Research output: Contribution to journal › Review article › peer-review

116 Citations (Scopus)

Abstract

Nanotechnology can profoundly change the way we diagnose and treat diseases, but the ability to control how engineered nanoparticles behave within the body remains largely elusive. This Commentary describes the progress and limitations of nanomedicine and the research and experimental philosophies that should be considered in our quest to advance nanotechnology to the clinic.

Original language	English
Pages (from-to)	627-632
Number of pages	6
Journal	Accounts of Chemical Research
Volume	50
Issue number	3
DOIs	https://doi.org/10.1021/acs.accounts.6b00629
Publication status	Published - Mar 21 2017
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2017 American Chemical Society.

ASJC Scopus Subject Areas

General Chemistry

Access to Document

10.1021/acs.accounts.6b00629

Cite this

@article{40bb566fb67641e499383a088dd7c4a8,

title = "Nanomedicine 2.0",

abstract = "Nanotechnology can profoundly change the way we diagnose and treat diseases, but the ability to control how engineered nanoparticles behave within the body remains largely elusive. This Commentary describes the progress and limitations of nanomedicine and the research and experimental philosophies that should be considered in our quest to advance nanotechnology to the clinic.",

author = "Chan, {Warren C.W.}",

note = "Publisher Copyright: {\textcopyright} 2017 American Chemical Society.",

year = "2017",

month = mar,

day = "21",

doi = "10.1021/acs.accounts.6b00629",

language = "English",

volume = "50",

pages = "627--632",

journal = "Accounts of Chemical Research",

issn = "0001-4842",

publisher = "American Chemical Society",

number = "3",

}

TY - JOUR

T1 - Nanomedicine 2.0

AU - Chan, Warren C.W.

PY - 2017/3/21

Y1 - 2017/3/21

N2 - Nanotechnology can profoundly change the way we diagnose and treat diseases, but the ability to control how engineered nanoparticles behave within the body remains largely elusive. This Commentary describes the progress and limitations of nanomedicine and the research and experimental philosophies that should be considered in our quest to advance nanotechnology to the clinic.

AB - Nanotechnology can profoundly change the way we diagnose and treat diseases, but the ability to control how engineered nanoparticles behave within the body remains largely elusive. This Commentary describes the progress and limitations of nanomedicine and the research and experimental philosophies that should be considered in our quest to advance nanotechnology to the clinic.

UR - http://www.scopus.com/inward/record.url?scp=85019853130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019853130&partnerID=8YFLogxK

U2 - 10.1021/acs.accounts.6b00629

DO - 10.1021/acs.accounts.6b00629

M3 - Review article

C2 - 28945418

AN - SCOPUS:85019853130

SN - 0001-4842

VL - 50

SP - 627

EP - 632

JO - Accounts of Chemical Research

JF - Accounts of Chemical Research

IS - 3

ER -

Nanomedicine 2.0

Abstract

Bibliographical note

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this